Corrections and clarifications
Muscle growth drug trial
An article about a drug trial stated that participants given apitegromab alongside tirzepatide lost on average 1.6kg of lean mass, while those given apitegromab alongside a placebo lost on average 3.5kg of lean mass. As mentioned elsewhere in the article, the drug given alongside the placebo was tirzepatide (Drug could reduce muscle loss for those using slimming jab, 9 June, p14, early editions). This error was in print only.
Other recently amended articles include:
- UK economy shrank by 0.1% in April as Iran war held back growth
- ‘I’m hoping to meet a river goddess’: a wild journey through Britain’s mythic waterways
Editorial complaints and correction requests can be sent to: guardian.readers@theguardian.com. You can also write to: Readers’ editor, Kings Place, 90 York Way, London N1 9GU, or leave a voicemail on +44 (0) 20 3353 4736.
—
Explore more on these topics
- Corrections and clarifications
